SCHEMBL7369949

SCHEMBL7369949

CC(=O)c1cc(O)c(O)c(C#N)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA5A P35218 2/20 0.43
LMNA P02545 3/20 0.41
CYP11B1 P15538 1/20 0.40
CYP11B2 P19099 1/20 0.40
KDM4E B2RXH2 3/20 0.39
FUT7 Q11130 2/20 0.39
TDP1 Q9NUW8 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
CA12 O43570 1/20 0.39
ALDH1A1 P00352 1/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
TP53 P04637 1/20 0.39
CA3 P07451 1/20 0.39
MAPT P10636 1/20 0.39
SELL P14151 1/20 0.39
HPGD P15428 1/20 0.39
SELP P16109 1/20 0.39
FUT4 P22083 1/20 0.39
CA4 P22748 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18629883 0.83 CA5A (0.42) CA5ALMNACYP11B1CYP11B2KDM4E
SCHEMBL8542530 0.82 CA12 (0.61) CA5ALMNAKDM4EFUT7TDP1
SCHEMBL22230775 0.81 TTR (0.42) CA5ALMNACYP11B1CYP11B2KDM4E
SCHEMBL8731830 0.79 KDM4E (0.42) CA5ALMNAKDM4EFUT7TDP1
SCHEMBL96069 0.79 LMNA (0.59) CA5ALMNAKDM4EFUT7TDP1
SCHEMBL7373598 0.78 KDM4E (0.44) CA5ALMNAKDM4EFUT7TDP1
SCHEMBL6970906 0.77 PKM (0.46) CA5ACYP11B1CYP11B2ALDH1A1MAPT
SCHEMBL7942553 0.77 PKM (0.50) CYP11B1CYP11B2ALDH1A1MAPTPOLB
SCHEMBL7368979 0.77 GSK3B (0.47) CA5ALMNAKDM4EFUT7TDP1
SCHEMBL7367283 0.75 CNR2 (0.62) TDP1ALDH1A1L3MBTL1SLC22A12CNR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5705703-A ENZYME INHIBITORS OF TRANSFERASES HOFFMANN-LA ROCHE INC. (US) 1998-01-06 US disclosed
US-5633371-A ENZYME INHIBITORS; TREATMENT OF DEPRESSION AND PARKINSON*S DISEASE HOFFMANN-LA ROCHE INC. (US) 1997-05-27 US disclosed
US-5476875-A Catechol derivatives HOFFMAN-LA ROCHE INC. (US) 1995-12-19 US disclosed
US-5389653-A Inhibitors of the enzyme catechol-O-methyltransferase; useful as co-medication in treatment of Parkinson's disease HOFFMAN-LA ROCHE INC. (US) 1995-02-14 US disclosed
US-5236952-A Inhibit the enzyme catechol-O-methyltransferase; for treatment of Parkinson's disease administered with L-dopa HOFFMANN-LA ROCHE INC. (US) 1993-08-17 US disclosed
EP-0237929-B1 3,5-DISUBSTITUTED PYROCATECHOL DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 1993-06-02 EP disclosed
EP-0237929-A1 3,5-Disubstituted pyrocatechol derivatives F. HOFFMANN-LA ROCHE AG (CH) 1987-09-23 EP disclosed